electroCore, Inc. (ECOR)
NASDAQ: ECOR · Real-Time Price · USD
6.78
+0.18 (2.65%)
At close: Apr 2, 2026, 4:00 PM EDT
6.80
+0.02 (0.37%)
After-hours: Apr 2, 2026, 4:10 PM EDT
electroCore Revenue
In the year 2025, electroCore had annual revenue of $32.03M with 27.20% growth. electroCore had revenue of $9.24M in the quarter ending December 31, 2025, with 31.18% growth.
Revenue (ttm)
$32.03M
Revenue Growth
+27.20%
P/S Ratio
1.72
Revenue / Employee
$385,928
Employees
83
Market Cap
54.97M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 32.03M | 6.85M | 27.20% |
| Dec 31, 2024 | 25.18M | 9.15M | 57.09% |
| Dec 31, 2023 | 16.03M | 7.44M | 86.57% |
| Dec 31, 2022 | 8.59M | 3.14M | 57.62% |
| Dec 31, 2021 | 5.45M | 1.96M | 55.93% |
| Dec 31, 2020 | 3.50M | 1.11M | 46.25% |
| Dec 31, 2019 | 2.39M | 1.40M | 140.72% |
| Dec 31, 2018 | 992.95K | 181.50K | 22.37% |
| Dec 31, 2017 | 811.46K | 557.32K | 219.30% |
| Dec 31, 2016 | 254.14K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Accuray | 436.97M |
| Xtant Medical Holdings | 133.93M |
| Pulmonx | 90.50M |
| Baird Medical Investment Holdings | 31.86M |
| Sensus Healthcare | 27.48M |
| Spectral AI | 19.65M |
| Elutia | 12.29M |
| Picard Medical | 4.94M |
ECOR News
- 3 days ago - electroCore Announces Publication in Frontiers in Neuroscience Highlighting Benefits of Non-Invasive Vagus Nerve Stimulation in Patients with Mild Traumatic Brain Injury and PTSD - GlobeNewsWire
- 5 days ago - electroCore Expands Intellectual Property Portfolio - GlobeNewsWire
- 9 days ago - Ecora Royalties PLC (ECOR:CA) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 16 days ago - electroCore, Inc. (ECOR) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 16 days ago - electroCore Announces Full Year 2025 Financial Results and Organizational Changes - GlobeNewsWire
- 25 days ago - electroCore to Participate at the 38th Annual Roth Conference - GlobeNewsWire
- 26 days ago - electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2025, Financial Results on Thursday, March 19, 2026 - GlobeNewsWire
- 2 months ago - Acacia Clinics and Vagus Nerve Society Conduct Study Using electroCore's gammaCore Sapphire for Adjunctive Treatment of Symptoms Associated with Post-Traumatic Stress Disorder (“PTSD”) - GlobeNewsWire